ProstACT Update: TARGET Study Ethics Approval ...Middle East

PR Newswire - News
ProstACT Update: TARGET Study Ethics Approval
MELBOURNE, Australia, April 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its ProstACT TARGET Phase II clinical trial of the Company's prostate cancer antibody therapy candidate TLX591 (177Lu-DOTA-rosopatamab), in patients...

Hence then, the article about prostact update target study ethics approval was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ProstACT Update: TARGET Study Ethics Approval )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News